Ad is loading...
AWH
Price
$0.72
Change
-$0.03 (-4.00%)
Updated
Nov 22, 02:02 PM (EDT)
XAIR
Price
$0.55
Change
+$0.03 (+5.77%)
Updated
Nov 22, 03:31 PM (EDT)
76 days until earnings call
Ad is loading...

AWH vs XAIR

Header iconAWH vs XAIR Comparison
Open Charts AWH vs XAIRBanner chart's image
Aspira Women's Health
Price$0.72
Change-$0.03 (-4.00%)
Volume$1K
CapitalizationN/A
Beyond Air
Price$0.55
Change+$0.03 (+5.77%)
Volume$447
CapitalizationN/A
AWH vs XAIR Comparison Chart
Loading...
AWH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AWH vs. XAIR commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWH is a StrongSell and XAIR is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (AWH: $0.75 vs. XAIR: $0.52)
Brand notoriety: AWH and XAIR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AWH: 29% vs. XAIR: 44%
Market capitalization -- AWH: $32.04M vs. XAIR: $79.87M
AWH [@Medical Specialties] is valued at $32.04M. XAIR’s [@Medical Specialties] market capitalization is $79.87M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AWH’s FA Score shows that 0 FA rating(s) are green whileXAIR’s FA Score has 1 green FA rating(s).

  • AWH’s FA Score: 0 green, 5 red.
  • XAIR’s FA Score: 1 green, 4 red.
According to our system of comparison, XAIR is a better buy in the long-term than AWH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AWH’s TA Score shows that 4 TA indicator(s) are bullish while XAIR’s TA Score has 5 bullish TA indicator(s).

  • AWH’s TA Score: 4 bullish, 6 bearish.
  • XAIR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, XAIR is a better buy in the short-term than AWH.

Price Growth

AWH (@Medical Specialties) experienced а +1.04% price change this week, while XAIR (@Medical Specialties) price change was -2.02% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.22%. For the same industry, the average monthly price growth was +1.01%, and the average quarterly price growth was -2.21%.

Reported Earning Dates

AWH is expected to report earnings on Aug 14, 2023.

XAIR is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Medical Specialties (+3.22% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XAIR($79.9M) has a higher market cap than AWH($32M). XAIR YTD gains are higher at: -73.505 vs. AWH (-81.672). AWH has higher annual earnings (EBITDA): -21.97M vs. XAIR (-67.06M). XAIR has more cash in the bank: 31.3M vs. AWH (5.1M). AWH has less debt than XAIR: AWH (2.34M) vs XAIR (16.9M). AWH has higher revenues than XAIR: AWH (9.18M) vs XAIR (689K).
AWHXAIRAWH / XAIR
Capitalization32M79.9M40%
EBITDA-21.97M-67.06M33%
Gain YTD-81.672-73.505111%
P/E RatioN/AN/A-
Revenue9.18M689K1,332%
Total Cash5.1M31.3M16%
Total Debt2.34M16.9M14%
FUNDAMENTALS RATINGS
AWH vs XAIR: Fundamental Ratings
AWH
XAIR
OUTLOOK RATING
1..100
5016
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
9253
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XAIR's Valuation (33) in the null industry is somewhat better than the same rating for AWH (66) in the Multi Line Insurance industry. This means that XAIR’s stock grew somewhat faster than AWH’s over the last 12 months.

XAIR's Profit vs Risk Rating (100) in the null industry is in the same range as AWH (100) in the Multi Line Insurance industry. This means that XAIR’s stock grew similarly to AWH’s over the last 12 months.

XAIR's SMR Rating (99) in the null industry is in the same range as AWH (100) in the Multi Line Insurance industry. This means that XAIR’s stock grew similarly to AWH’s over the last 12 months.

XAIR's Price Growth Rating (53) in the null industry is somewhat better than the same rating for AWH (92) in the Multi Line Insurance industry. This means that XAIR’s stock grew somewhat faster than AWH’s over the last 12 months.

XAIR's P/E Growth Rating (100) in the null industry is in the same range as AWH (100) in the Multi Line Insurance industry. This means that XAIR’s stock grew similarly to AWH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AWHXAIR
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
AWH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADEA12.100.58
+5.03%
Adeia
CRVL360.194.96
+1.40%
CorVel Corp
GROY1.310.01
+0.77%
Gold Royalty Corp
EA167.971.26
+0.76%
Electronic Arts
MRM2.88-0.01
-0.41%
MEDIROM Healthcare Technologies

AWH and

Correlation & Price change

A.I.dvisor tells us that AWH and ALGN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AWH and ALGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AWH
1D Price
Change %
AWH100%
+2.44%
ALGN - AWH
26%
Poorly correlated
+1.94%
XAIR - AWH
25%
Poorly correlated
+5.63%
GENE - AWH
23%
Poorly correlated
N/A
ITGR - AWH
23%
Poorly correlated
+1.88%
NVST - AWH
23%
Poorly correlated
+5.01%
More

XAIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XAIR has been loosely correlated with OPK. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XAIR jumps, then OPK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XAIR
1D Price
Change %
XAIR100%
+5.63%
OPK - XAIR
35%
Loosely correlated
-1.27%
KIDS - XAIR
32%
Poorly correlated
+3.80%
SHWGY - XAIR
32%
Poorly correlated
+1.56%
CERS - XAIR
31%
Poorly correlated
+0.60%
IDXX - XAIR
31%
Poorly correlated
-0.01%
More